TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.

Silvia Novello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.